AU6069486A - Cephalosporin salts and injectable compositions - Google Patents

Cephalosporin salts and injectable compositions

Info

Publication number
AU6069486A
AU6069486A AU60694/86A AU6069486A AU6069486A AU 6069486 A AU6069486 A AU 6069486A AU 60694/86 A AU60694/86 A AU 60694/86A AU 6069486 A AU6069486 A AU 6069486A AU 6069486 A AU6069486 A AU 6069486A
Authority
AU
Australia
Prior art keywords
injectable compositions
cephalosporin salts
cephalosporin
salts
injectable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU60694/86A
Other versions
AU597262B2 (en
Inventor
Thomas W. Hudyma
Murray A. Kaplan
Robert A. Lipper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of AU6069486A publication Critical patent/AU6069486A/en
Application granted granted Critical
Publication of AU597262B2 publication Critical patent/AU597262B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
AU60694/86A 1985-08-05 1986-07-30 Cephalosporin salts and injectable compositions Expired AU597262B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76223585A 1985-08-05 1985-08-05
US762235 1985-08-05

Publications (2)

Publication Number Publication Date
AU6069486A true AU6069486A (en) 1987-02-12
AU597262B2 AU597262B2 (en) 1990-05-31

Family

ID=25064475

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60694/86A Expired AU597262B2 (en) 1985-08-05 1986-07-30 Cephalosporin salts and injectable compositions

Country Status (34)

Country Link
JP (1) JPH0615548B2 (en)
KR (1) KR930003121B1 (en)
AR (1) AR243894A1 (en)
AT (1) AT390957B (en)
AU (1) AU597262B2 (en)
BE (1) BE905219A (en)
CA (1) CA1284994C (en)
CH (1) CH675581A5 (en)
CS (2) CS276849B6 (en)
CY (1) CY1614A (en)
DD (2) DD254941A5 (en)
DE (1) DE3626375A1 (en)
DK (1) DK162053C (en)
EG (1) EG18003A (en)
ES (1) ES2002112A6 (en)
FI (1) FI84484C (en)
FR (1) FR2585705B1 (en)
GB (1) GB2179936B (en)
GR (1) GR862055B (en)
HK (1) HK99691A (en)
HU (1) HU196602B (en)
IE (1) IE59222B1 (en)
IL (1) IL79608A (en)
IT (1) IT1197067B (en)
LU (2) LU86540A1 (en)
MY (1) MY102212A (en)
NL (1) NL8601991A (en)
OA (1) OA08672A (en)
PT (1) PT83134B (en)
SE (1) SE469633B (en)
SG (1) SG79791G (en)
SU (1) SU1516013A3 (en)
YU (1) YU45793B (en)
ZA (1) ZA865842B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883868A (en) * 1984-12-27 1989-11-28 Banyu Pharmaceutical Co., Ltd. 7-amino-3-(substituted isoindolinium)methyl-3-cephem derivatives
US4959469A (en) * 1984-12-27 1990-09-25 Banyu Pharmaceutical Company, Ltd. Crystalline cephalosporin compounds
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
EP0321562B1 (en) * 1987-06-25 1993-11-24 Banyu Pharmaceutical Co., Ltd. Crystalline cephalosporin compounds, process for their preparation, and intermediates for their preparation
JPH02101081A (en) * 1988-10-08 1990-04-12 Meiji Seika Kaisha Ltd Crystalline dihydrochloride of cephalosporin derivative and production thereof
CA2011116C (en) * 1989-03-06 1999-11-16 Murray A. Kaplan Lyophilized bmy-28142 dihydrochloride for parenteral use
CA2101571A1 (en) * 1992-09-08 1994-03-09 Elizabeth A. Garofalo Crystalline dihydrate of a cephalosporin dihydrate salt and injectable compositions thereof
EP0638573A1 (en) * 1993-08-10 1995-02-15 Lucky Ltd. Crystalline hydrates of cephalosporin and process for preparation thereof
DE602004011685T2 (en) 2003-12-23 2009-02-05 Sandoz Gmbh PROCESS FOR PREPARING INTERMEDIATE PRODUCTS FOR USE IN THE CEFALOSPORIN SYNTHESIS
WO2008056221A2 (en) * 2006-11-06 2008-05-15 Orchid Chemicals & Pharmaceuticals Limited Crystalline sulfate salt of cephalosporin antibiotic
DE102012101680A1 (en) * 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Pharmaceutical preparation containing an antiviral dihydroquinazoline derivative

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
DE3419015A1 (en) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen METHOD FOR PRODUCING CEPHALOSPORINES
GB8424692D0 (en) * 1984-10-01 1984-11-07 Glaxo Group Ltd Chemical compounds
GB2165245B (en) * 1984-10-01 1988-05-25 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
SE8603308D0 (en) 1986-08-04
CS276717B6 (en) 1992-08-12
IE59222B1 (en) 1994-01-26
KR930003121B1 (en) 1993-04-19
SE8603308L (en) 1987-02-06
FR2585705B1 (en) 1989-01-13
DE3626375A1 (en) 1987-02-12
AU597262B2 (en) 1990-05-31
FR2585705A1 (en) 1987-02-06
JPH0615548B2 (en) 1994-03-02
IT8621409A1 (en) 1988-02-04
ZA865842B (en) 1987-04-29
DK162053C (en) 1992-02-10
DD254941A5 (en) 1988-03-16
FI84484B (en) 1991-08-30
IL79608A0 (en) 1986-11-30
AT390957B (en) 1990-07-25
YU45793B (en) 1992-07-20
HU196602B (en) 1988-12-28
FI84484C (en) 1991-12-10
PT83134B (en) 1989-07-31
GB2179936B (en) 1989-04-26
CA1284994C (en) 1991-06-18
DD268395A5 (en) 1989-05-31
IL79608A (en) 1991-07-18
GB8618989D0 (en) 1986-09-17
GR862055B (en) 1986-12-24
BE905219A (en) 1987-02-04
IE862078L (en) 1987-02-05
FI863155A0 (en) 1986-08-01
IT1197067B (en) 1988-11-25
FI863155A (en) 1987-02-06
SG79791G (en) 1991-11-15
JPS62103090A (en) 1987-05-13
DK162053B (en) 1991-09-09
CH675581A5 (en) 1990-10-15
OA08672A (en) 1989-03-31
IT8621409A0 (en) 1986-08-04
PT83134A (en) 1986-09-01
SU1516013A3 (en) 1989-10-15
CS276849B6 (en) 1992-08-12
SE469633B (en) 1993-08-09
AR243894A1 (en) 1993-09-30
LU88574I2 (en) 1995-03-01
ES2002112A6 (en) 1988-07-16
DK371886A (en) 1987-02-06
GB2179936A (en) 1987-03-18
HK99691A (en) 1991-12-13
CY1614A (en) 1992-07-10
MY102212A (en) 1992-05-15
NL8601991A (en) 1987-03-02
DK371886D0 (en) 1986-08-04
HUT41802A (en) 1987-05-28
KR880002530A (en) 1988-05-09
EG18003A (en) 1991-08-30
ATA211086A (en) 1990-01-15
LU86540A1 (en) 1987-03-06
YU137186A (en) 1987-12-31

Similar Documents

Publication Publication Date Title
ZA89407B (en) Cephalosporin salts and injectable compositions
NZ215333A (en) Cephem compounds and pharmaceutical compositions
AU6069486A (en) Cephalosporin salts and injectable compositions
PH23045A (en) Cephem derivative and composition containing said compound
AU628664B2 (en) Cephalosporin compound and pharmaceutical composition thereof
NZ212320A (en) Cephalosporin derivatives and pharmaceutical compositions
NZ215717A (en) Cephalosporin derivatives
AU575715B2 (en) Lubricating composition with naphenate salts and polyesters
AU6697086A (en) Immunoamplifiers and related compositions
AU5556886A (en) O-sulfated beta-lactam hydrozamic acids
PH23442A (en) Cephalosporin derivatives and salts thereof
AU578677B2 (en) cephalosporin derivatives and salts thereof
AU608505B2 (en) Anaerobe-selective antibacterial compositions and methods
NZ217519A (en) Carbapenem antibiotics and compositions
AU4354385A (en) Cephalosporin derivatives
NZ210761A (en) Cephalosporin derivatives and pharmaceutical compositions
PH21201A (en) Cephalosporin derivatives and salts thereof
NZ216624A (en) Cephalosporins and pharmaceutical compositions
IL88959A (en) Cephalosporin salts and injectable compositions
AU557332B2 (en) Cephalosporin derivatives
AU584152B2 (en) Copolyestercarbonate composition
IE850040L (en) Cephalosporin derivatives
IE850448L (en) Cephalosporin derivatives
IL79200A0 (en) Cephalosporin derivatives
ZA862347B (en) Cephalosporin derivatives